Patents by Inventor John L. Sands

John L. Sands has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11970969
    Abstract: An exhaust device for a compressor bypass bleed system of a ducted fan engine includes a housing having an inlet end and an outlet end and defining a centerline axis from the inlet end to the outlet end, an inlet flow conditioner arranged at the inlet end, the inlet flow conditioner including a plurality of inlet openings for conducting a flow of compressed air therethrough into the housing, and an exit screen arranged at the outlet end of the housing. The exit screen includes a plurality of exit openings therethrough arranged at an acute angle with respect to the centerline axis so as to provide a flow of compressed air therethrough into a bypass flow passage at least partially in a same direction as a bypass airflow through the bypass flow passage.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: April 30, 2024
    Assignee: GENERAL ELECTRIC COMPANY
    Inventors: Thomas L. Pugh, Mark E. Linz, Jarrod Paul Sands, John J. Rahaim
  • Patent number: 5328983
    Abstract: The invention relates to a process for the purification of brominated styrenic homo-polymers and co-polymers. The purification process reduces or removes contained aliphatic bromine, and free bromine resulting from the reaction of the brominated reagent with the polystyrene backbone. In addition, the method optionally removes occluded inorganic halide impurities from the polymer. These impurities are considered undesirable due to their adverse effects on thermal aging and stability of the final end use resin formulations.
    Type: Grant
    Filed: March 2, 1992
    Date of Patent: July 12, 1994
    Assignee: Great Lakes Chemical Corporation
    Inventors: Nicolai A. Favstritsky, William R. Fielding, John L. Sands, Robert J. Stahl
  • Patent number: 4879353
    Abstract: A process for the bromination of polystyrenic homo- and co-polymers using bromine as the reaction medium, bromine chloride as the bromination reagent and a Lewis acid catalyst substantially improves product quality and permits controlling the reaction to achieve a desired level of bromination.
    Type: Grant
    Filed: October 28, 1988
    Date of Patent: November 7, 1989
    Assignee: Great Lakes Chemical Corporation
    Inventors: David C. Sanders, John L. Sands, Joseph L. Stahl
  • Patent number: 4327227
    Abstract: Highly purified brominated aromatic compounds such as decabromodiphenyl ether, pentabromophenol, and the like may be obtained by grinding the crude brominated product to provide particles predominantly less than about 20 microns in diameter and thereafter heating the crude ground brominated product for a time and at a temperature in order to effect substantial removal of the bromine and hydrogen bromide impurities therefrom. Optionally, the product may be ground a second time after the heating step to optimize product particle size and liberate residual impurities. The foregoing procedure is especially effective where the brominated compound is a thermally stable solid under the conditions of treatment and is substantially free from impurities containing aliphatic and alicyclic hydrocarbon groups.
    Type: Grant
    Filed: July 8, 1980
    Date of Patent: April 27, 1982
    Assignee: Great Lakes Chemical Corporation
    Inventors: James T. Ayres, David L. McAllister, John L. Sands
  • Patent number: 4287373
    Abstract: A process for the perbromination of phenol and diphenyl ether by brominating the corresponding compound in bromine as the sole reaction medium using metal and metal-containing catalysts at an elevated initial reaction temperature of at least about 35.degree. C., preferably at least about 45.degree. C., substantially enhances reaction productivity without adversely affecting product yield or quality.
    Type: Grant
    Filed: October 1, 1979
    Date of Patent: September 1, 1981
    Assignee: Great Lakes Chemical Corporation
    Inventors: John A. Garman, Rastko I. Mamuzic, Robert B. McDonald, John L. Sands, Gregory Thompson
  • Patent number: 4208419
    Abstract: Benzimidazolyl, benzothiazolyl and benzoxazolyl ureas and thioureas are employed as immune regulatory agents, as agents capable of altering the immune response in mammals.
    Type: Grant
    Filed: November 30, 1978
    Date of Patent: June 17, 1980
    Assignee: Eli Lilly and Company
    Inventors: Charles J. Paget, John L. Sands
  • Patent number: 4171364
    Abstract: Benzimidazolyl, benzothiazolyl and benzoxazolyl ureas and thioureas are employed as immune regulatory agents, as agents capable of altering the immune response in mammals.
    Type: Grant
    Filed: November 30, 1978
    Date of Patent: October 16, 1979
    Assignee: Eli Lilly and Company
    Inventors: Charles J. Paget, John L. Sands
  • Patent number: 4160112
    Abstract: A process for isolating crude pentabromophenol containing occluded bromine and hydrogen bromide as impurities comprising the steps of contacting the crude pentabromophenol with a strong acid such as hydrobromic acid, sulfuric acid, hydrochloric acid and phosphoric acid; heating the mixture in order to remove excess bromine; and recovering of the pentabromophenol, whereby formation of carbonyl-group-containing impurities during isolation is minimized.
    Type: Grant
    Filed: February 13, 1978
    Date of Patent: July 3, 1979
    Assignee: Great Lakes Chemical Corporation
    Inventors: Robert P. Levek, Rastko I. Mamuzic, John L. Sands
  • Patent number: 4153709
    Abstract: Benzimidazolyl, benzothiazolyl and benzoxazolyl ureas and thioureas are employed as immune regulatory agents, as agents capable of altering the immune response in mammals.
    Type: Grant
    Filed: October 20, 1977
    Date of Patent: May 8, 1979
    Assignee: Eli Lilly and Company
    Inventors: Charles J. Paget, John L. Sands
  • Patent number: 4088768
    Abstract: Benzimidazolyl, benzothiazolyl and benzoxazolyl ureas and thioureas are employed as immune regulatory agents, as agents capable of altering the immune response in mammals.
    Type: Grant
    Filed: January 21, 1976
    Date of Patent: May 9, 1978
    Assignee: Eli Lilly and Company
    Inventors: Charles J. Paget, John L. Sands